Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,425.00    0.00 (0.00%)
Bid:
5,400.00
Ask:
5,600.00
Spread: 200.00 (3.704%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Trading Update

5 Aug 2014 10:16

RNS Number : 2742O
Camellia PLC
05 August 2014
 

5 August 2014

 

Camellia Plc

(the "Company")

 

Trading update

 

The Company wishes to make the following update on trading. As previously indicated, climactic conditions have affected a number of our agricultural operations for example in India and Bangladesh, where droughts have resulted in lost tea production and in California where our citrus crop was severely damaged by frost resulting in significantly reduced production. The lost production in these operations is unlikely to be recovered this year.

 

Our Indian tea sale prices have been satisfactory, but those in Bangladesh, as a result of cheaper imports, have been substantially lower than in 2013. Sale prices achieved recently in Bangladesh are showing some signs of recovery following an increase in import duties, but remain at materially lower levels than last year. 

 

The performance of our African tea businesses remains very disappointing due to substantially reduced tea sale prices in both Kenya and Malawi, although crops are ahead of budget. 

 

It is disappointing to report that a substantial loss has arisen from changes in the fair value of Biological Assets, primarily as a result of an 8 per cent. revaluation of the Malawi kwacha against the US$ during the period to 30 June 2014. 

 

As previously announced, trading at our Engineering division and at Duncan Lawrie are challenging, with problems remaining at AKD as a result of a protracted and ongoing legal dispute. At Duncan Lawrie income is lower than in the previous period due to reductions in banking and investment management income and additional costs that have been incurred as a consequence of certain changes to management. 

 

The cumulative effect of these items is that the results for the six months to 30 June 2014 are expected to be significantly below those achieved for the same period last year and are likely to show a loss. The profits lost in the first half are unlikely to be fully recouped in the second half of the year, though as is usual, the Company expects the results of the remainder of the year to show an improvement on the first half due to the cyclical nature of the business which is normally second half weighted.

 

The interim results will be announced on 28 August 2014.

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Anil Mathur, Finance Director

Julia Morton, Company Secretary

 

Charles Stanley Securities 020 7149 6000

Russell Cook

Carl Holmes

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGCGDISBGBGSU
Date   Source Headline
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20258:29 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTrading Update
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSDisposal
5th Dec 20247:00 amRNSDisposal
11th Nov 20248:06 amRNSSale of Bangladesh associate companies
31st Oct 202411:37 amRNSDisposal
25th Oct 202412:51 pmRNSHolding(s) in Company
17th Oct 20247:00 amRNSTrading Statement
6th Sep 202411:44 amRNSInterim Report 2024
6th Sep 20247:00 amRNSHalf-year Report
1st Jul 20247:00 amRNSDirector Changes
28th Jun 20241:00 pmRNSUpdate on BF&M Transaction
7th Jun 202411:14 amRNSResult of AGM
6th Jun 20247:00 amRNSTrading Update
1st May 202412:30 pmRNSAnnual Report & Notice of Annual General Meeting
29th Apr 20247:00 amRNSFinal Results
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.